Experience in production of 68Ga-DOTA-NOC for clinical use under an Expanded Access IND

This publication has 12 references indexed in Scilit:

• Radiosynthesis of clinical doses of 68 Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based 68 Ge/ 68 Ga generators
  Nuclear Medicine and Biology, 2015
• Ethanol-Based Post-processing of Generator-Derived ⁶⁸Ga Toward Kit-Type Preparation of ⁶⁸Ga-Radiopharmaceuticals
  Journal of Nuclear Medicine, 2014
• A new automated NaCl based robust method for routine production of gallium-68 labeled peptides
  Applied Radiation and Isotopes, 2013
• Multivisceral Transplantation: Expanding Indications and Improving Outcomes
  Journal of Gastrointestinal Surgery, 2013
• Maturation of a Key Resource – The Germanium-68/Gallium-68 Generator: Development and New Insights
  Current Radiopharmaceuticals, 2012
• ⁶⁸Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors
  Journal of Nuclear Medicine, 2010
• Detection of unknown primary neuroendocrine tumours (CUP-NET) using 68Ga-DOTA-NOC receptor PET/CT
  European Journal of Nuclear Medicine and Molecular Imaging, 2009
• Radiolabelling, quality control and radiochemical purity assessment of the Octreotide analogue 68Ga DOTA NOC
  Applied Radiation and Isotopes, 2008
• 68Ga-DOTANOC: biodistribution and dosimetry in patients affected by neuroendocrine tumors
  European Journal of Nuclear Medicine and Molecular Imaging, 2007
• Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
  European Journal of Nuclear Medicine and Molecular Imaging, 2007